Ameriprise
YARW

Ameriprise’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Ameriprise’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21
Closed -$7K – 4032
2022
Q2 		$7K Sell
21
-3
-13% -$1.26K ﹤0.01% 3869
2022
Q1 		$14K Hold
24
– – ﹤0.01% 3910
2021
Q4 		$22K Sell
24
-12
-33% -$12.9K ﹤0.01% 3926
2021
Q3 		$45K Hold
36
– – ﹤0.01% 3819
2021
Q2 		$113K Hold
36
– – ﹤0.01% 3810
2021
Q1 		$220K Sell
36
-17
-32% -$123K ﹤0.01% 3683
2020
Q4 		$303K Sell
53
-12
-18% -$75.4K ﹤0.01% 3500
2020
Q3 		$391K Sell
65
-17
-21% -$99.2K ﹤0.01% 3327
2020
Q2 		$520K Buy
82
+54
+193% +$366K ﹤0.01% 3185
2020
Q1 		$273K Sell
28
-207
-88% -$3.25M ﹤0.01% 3336
2019
Q4 		$3.92M Buy
+235
New +$3.92M ﹤0.01% 2374
2019
Q3 		– Sell
-5
Closed -$102K – 3774
2019
Q2 		$102K Hold
5
– – ﹤0.01% 3660
2019
Q1 		$141K Hold
5
– – ﹤0.01% 3605
2018
Q4 		$74K Buy
+5
New +$112K ﹤0.01% 3554

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Ameriprise's YARW Position: Q3 2022 in Review

Ameriprise sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2022, closing a stake of 21 shares — an estimated $7K sold.

Ameriprise first reported a position in YARW in Q4 2018 and held it in 14 quarters. The position peaked at $3.92M in Q4 2019. 37 funds tracked by Wall St. Rank hold YARW as of Q3 2022.

  • Ameriprise reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ameriprise sold 21 Yarrow Bioscience, Inc. Common Stock shares in Q3 2022, an estimated $7K.
  • Ameriprise first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2018 and held it in 14 quarters.
  • Ameriprise's Yarrow Bioscience, Inc. Common Stock position peaked at $3.92M in Q4 2019.
  • 37 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2022.

Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.